Landmark trial
Hypofractionated Versus Single-Session Radiosurgery to Preserve Hearing in Patients Affected by Sporadic Vestibular Schwannoma: The ACOUNEU Randomized Clinical Trial
Marchetti M, Pinzi V, Gemma M, et al.
DoseLab summary
Randomized trial comparing single-session with 3-fraction radiosurgery for sporadic vestibular schwannoma, with hearing preservation as the aim. eviQ cites it for its cochlear mean-dose goals in brain metastasis SRS. Citation checked against Crossref.
Why this is useful
A recent randomized source for cochlear dose in radiosurgery.
Reference details
- Title
- Hypofractionated Versus Single-Session Radiosurgery to Preserve Hearing in Patients Affected by Sporadic Vestibular Schwannoma: The ACOUNEU Randomized Clinical Trial
- Authors / organization
- Marchetti M, Pinzi V, Gemma M, et al.
- Publication / protocol
- Int J Radiat Oncol Biol Phys. 2025;123(1):107–117
- Version
- Pending verification
- Year
- 2025
- DOI
- 10.1016/j.ijrobp.2025.03.081
- Disease sites
- CNS / Brain
- Topics
- SRS, Cochlea, Hearing, Vestibular schwannoma
- Fractionation context
- 1 fx vs 3 fx radiosurgery
- Last reviewed by DoseLab
- Pending verification